Publications by authors named "Addie Dvir"

Claim this Profile
L
Liquid First Is "Solid" in Naïve Non-Small Cell Lung Cancer Patients: Faster Turnaround Time With High Concordance to Solid Next-Generation Sequencing.
Or Sehayek, Waleed Kian, Amir Onn, Ronen Stoff, Hadas Gantz Sorotsky, Addie Dvir

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).
Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, Suyog Jain, Steve Olsen, Addie Dvir

J Clin Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of osimertinib' line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistance.
Vered Fuchs, Laila Roisman, Waleed Kian, Levin Daniel, Julia Dudnik, Addie Dvir

Lung Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Blood-based Liquid Biopsy in Patients with Treatment-naïve Metastatic Adenocarcinoma of the Lung: A Case Series.
Michael Peled, Jair Bar, Liat Avni, Sumit Chatterji, Dafna Somech, Addie Dvir

Isr Med Assoc J· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Impact of Comprehensive Genomic Testing of Circulating Cell-Free DNA in Advanced Lung Cancer.
Smadar Laufer-Geva, Anna Belilovski Rozenblum, Tal Twito, Roxana Grinberg, Addie Dvir

J Thorac Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Cell-Free Tumor DNA in the Management of Double Primary Tumors.
Elizabeth Dudnik, Tal Twito, Iris Faull, Addie Dvir, Lior Soussan-Gutman

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience.
Ofer Purim, Alexander Beny, Moshe Inbar, Katerina Shulman, Baruch Brenner, Addie Dvir

Target Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[THE IMPACT OF MOLECULAR PROFILING USING NEXT-GENERATION SEQUENCING IN ADVANCED LUNG CANCER].
Anna Belilovski Rozenblum, Maya Ilouze, Elizabeth Dudnik, Lior Soussan-Gutman, Addie Dvir

Harefuah· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.
Michal Sarfaty, Assaf Moore, Victoria Neiman, Elizabeth Dudnik, Maya Ilouze, Addie Dvir

Clin Lung Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer.
Nir Peled, Laila C Roisman, Benjamin Miron, Raphael Pfeffer, Richard B Lanman, Addie Dvir

J Thorac Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer.
Anna Belilovski Rozenblum, Maya Ilouze, Elizabeth Dudnik, Addie Dvir, Lior Soussan-Gutman

J Thorac Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients.
Deborah T Blumenthal, Addie Dvir, Alexander Lossos, Tzahala Tzuk-Shina, Tzach Lior

J Neurooncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy.
Aron Popovtzer, Michal Sarfaty, Dror Limon, Gideon Marshack, Eli Perlow, Addie Dvir

Biomed Res Int· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive Genomic Profiling Identifies Frequent Drug-Sensitive EGFR Exon 19 Deletions in NSCLC not Identified by Prior Molecular Testing.
Alexa B Schrock, Garrett M Frampton, Dana Herndon, Joel R Greenbowe, Kai Wang, Addie Dvir

Clin Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
Ron Epelbaum, Einat Shacham-Shmueli, Baruch Klein, Abed Agbarya, Baruch Brenner, Addie Dvir

Biomed Res Int· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
Tamar Yablonski-Peretz, Shani Paluch-Shimon, Lior Soussan Gutman, Yulia Kaplan, Addie Dvir

Breast Cancer Res Treat· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir

Oncologist· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone dependent metastatic salivary gland carcinoma: a case report.
Abed Agbarya, Salem Billan, Haitam Nasrallah, Addie Dvir, Lior Soussan-Gutman

Springerplus· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.
Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Garrett Frampton, Funda Meric-Bernstam, Addie Dvir

Clin Cancer Res· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D538G mutation in estrogen receptor-α: A novel mechanism for acquired endocrine resistance in breast cancer.
Keren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, Addie Dvir, Lior Soussan-Gutman

Cancer Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis